Skip to content

NFL Dynamics as a Predictor Factor in Patients With Out of Hospital Cardiac Arrest

Dynamics of Light Chain of NFL as a Predictor Factor of Neurological Outcome in Patients With Out of Hospital Cardiac Arrest

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05218278
Enrollment
60
Registered
2022-02-01
Start date
2022-01-01
Completion date
2026-12-31
Last updated
2025-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neurological Injury, Out-Of-Hospital Cardiac Arrest

Brief summary

To investigate the pharmacodynamics of light chain of NFL in patients with out-of hospital cardiac arrest after successful resuscitation and determine the difference in the serum levels of NFL in patients with favorable neurological outcome compared to those with non-favorable neurological outcome.

Detailed description

To investigate the serum levels of the light chain of NFL at different time points after ICU admission (12, 24, 30, 36, 42, 48 hours after ICU admission) patients with out-of hospital cardiac arrest after successful resuscitation and determine the difference in the serum levels of NFL in patients with favorable neurological outcome compared to those with non-favorable neurological outcome.

Interventions

None listed

Sponsors

University Medical Centre Maribor
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* out-of-hospital cardiac arrest successfully resuscitated and admitted to the ICU

Exclusion criteria

* trauma, drowning, electrocution, less than 18 years of age,

Design outcomes

Primary

MeasureTime frameDescription
The difference in the dynamics of serum NFL levels measurements in patients with favorable neurological outcome compared to patients with non-favorable neurological outcome3 yearsNFL levels

Countries

Slovenia

Contacts

Primary ContactMatej Strnad, MD, PhD
strnad.matej78@gmail.com+38651225448

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026